Latest filing published 24 Jan 2023 for Pear Therapeutics, Inc., €13k.
No signal scores available.
All filings by Ronan O'Brien on record concern Pear Therapeutics, Inc. We count 2 filings; the first trade dates from 14 January 2023 and the latest from 20 January 2023.
Every open-market trade on record is a sale: 1 sale worth €13k. Outside the open market, there are 1 option exercise.
On 24 January 2023 came the latest disclosure, an open-market sale for €13k in Pear Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations